Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis-Reference-Cited by-同舟云学术

Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis

Published:2022-11-01 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Serrano Del Valle Alfonso¹^ORCID,Beltrán-Visiedo Manuel¹^ORCID,de Poo-Rodríguez Victoria²³^ORCID,Jiménez-Alduán Nelia¹,Azaceta Gemma²³^ORCID,Díez Rosana¹⁴,Martínez-Lázaro Beatriz²³,Izquierdo Isabel¹⁴,Palomera Luis²³^ORCID,Naval Javier¹^ORCID,Anel Alberto¹,Marzo Isabel¹^ORCID

Affiliation:

1. Apoptosis, Immunity & Cancer Group, IIS Aragón, University of Zaragoza, 50009 Zaragoza, Spain

2. Hematology Service, Hospital Clínico Universitario Lozano Blesa, 50009 Zaragoza, Spain

3. HCU-Lozano Blesa-Hematology Research Group, IIS Aragón, 50009 Zaragoza, Spain

4. Hematology Service, Hospital Universitario Miguel Servet, 50009 Zaragoza, Spain

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2141973

Reference64 articles.

1. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

2. Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics

3. Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer

4. Calreticulin is a Critical Cell Survival Factor in Malignant Neoplasms

5. Emerging Roles of Calreticulin in Cancer: Implications for Therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reactive oxygen species of tumor microenvironment: Harnessing for immunogenic cell death;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination;Cancer Letters;2024-08

3. Quercetin and taxifolin inhibits TMPRSS2 activity and its interaction with EGFR in paclitaxel‐resistant breast cancer cells: An in silico and in vitro study;Chemical Biology & Drug Design;2024-07-29

4. Cytofluorometric assessment of calreticulin exposure on CD38+ plasma cells from the human bone marrow;Methods in Cell Biology;2024

5. Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients;International Journal of Molecular Sciences;2023-09-19